Brian Baranick Exact Sciences Corp (EXAS) insider trading activity

Brian Baranick is EVP, GM, Precision Oncology of EXACT SCIENCES CORP. Currently has a direct ownership of 103,874 shares of EXAS, which is worth approximately $6.96 Million. The most recent transaction as insider was on Dec 24, 2025, when has been sold 14,938 shares (Common Stock) at a price of $101.59 per share, resulting in proceeds of $1,517,551. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 104K

311.77% 3M change

714.19% 12M change

Total Value Held $6.96 Million

Brian Baranick Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 24 2025	SELL Payment of exercise price or tax liability	$1,517,551 $101.59 p/Share	14,938 Reduced 12.57%	103,874 Common Stock
Dec 24 2025	BUY Grant, award, or other acquisition	-	29,416 Added 19.85%	118,812 Common Stock
Dec 23 2025	SELL Payment of exercise price or tax liability	$7,041,769 $101.82 p/Share	69,159 Reduced 43.62%	89,396 Common Stock
Dec 23 2025	BUY Exercise of conversion of derivative security	-	73,080 Added 52.36%	66,487 Common Stock
Dec 23 2025	BUY Grant, award, or other acquisition	-	63,107 Added 38.73%	99,849 Common Stock
Nov 04 2025	SELL Open market or private sale	$200,288 $70.08 p/Share	2,858 Reduced 11.33%	22,368 Common Stock
Aug 05 2025	SELL Payment of exercise price or tax liability	$127,237 $46.83 p/Share	2,717 Reduced 9.72%	25,226 Common Stock

Aug 05 2025	BUY Exercise of conversion of derivative security	-	5,350 Added 16.07%	27,943 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$234,939 $47.82 p/Share	4,913 Reduced 17.86%	22,593 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	9,673 Added 27.81%	25,106 Common Stock
Feb 25 2025	SELL Payment of exercise price or tax liability	$102,970 $51.28 p/Share	2,008 Reduced 10.12%	17,833 Common Stock
Feb 25 2025	BUY Exercise of conversion of derivative security	-	3,954 Added 16.62%	19,841 Common Stock
Feb 20 2025	SELL Payment of exercise price or tax liability	$123,019 $50.48 p/Share	2,437 Reduced 13.3%	15,887 Common Stock
Feb 20 2025	BUY Grant, award, or other acquisition	-	4,805 Added 20.77%	18,324 Common Stock
Feb 19 2025	SELL Payment of exercise price or tax liability	$48,041 $49.63 p/Share	968 Reduced 6.68%	13,519 Common Stock
Feb 19 2025	BUY Exercise of conversion of derivative security	-	1,729 Added 10.66%	14,487 Common Stock
Oct 08 2024	SELL Open market or private sale	$65,030 $70.0 p/Share	929 Reduced 6.79%	12,758 Common Stock
Sep 18 2024	SELL Open market or private sale	$65,030 $70.0 p/Share	929 Reduced 6.36%	13,687 Common Stock
Aug 05 2024	SELL Payment of exercise price or tax liability	$76,683 $55.77 p/Share	1,375 Reduced 8.6%	14,616 Common Stock
Aug 05 2024	BUY Exercise of conversion of derivative security	-	2,712 Added 14.5%	15,991 Common Stock
May 01 2024	SELL Open market or private sale	$6,616 $60.15 p/Share	110 Reduced 0.82%	13,279 Common Stock
Apr 30 2024	BUY Grant, award, or other acquisition	-	218 Added 1.6%	13,389 Common Stock
Apr 02 2024	SELL Open market or private sale	$73,393 $79.43 p/Share	924 Reduced 6.56%	13,171 Common Stock
Mar 01 2024	SELL Open market or private sale	$137,800 $59.32 p/Share	2,323 Reduced 14.15%	14,095 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	-	4,724 Added 22.34%	16,418 Common Stock

Brian Baranick

EVP, GM, Precision Oncology

Madison, WI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Value

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

Operation

Value

Type

News

Receive news related to EXACT SCIENCES CORP

Track Activities on EXAS

Account